Evidence map›Paper›PMID 34341960›Full record

ArticleJournal of neurovirology2021

Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?

Elisa Mantovani, Sara Mariotto, Daniele Gabbiani, Gianluigi Dorelli, Silvia Bozzetti, Angela Federico, Serena Zanzoni, Domenico Girelli, Ernesto Crisafulli, Sergio Ferrari and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurovirology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Not myopathic, but autonomic changes in patients with long-COVID syndrome: a case series.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Elisa MantovaniDepartment of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Verona, Italy. elisa.mantovani@univr.it.ORCID 0000-0003-3717-7697
Sara MariottoDepartment of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Verona, Italy.
Daniele GabbianiDepartment of Medicine, Internal Medicine Section D, University of Verona, Verona, Italy.
Gianluigi DorelliDepartment of Medicine, Internal Medicine Section D, University of Verona, Verona, Italy.
Silvia BozzettiDepartment of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Verona, Italy.
Angela FedericoDepartment of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Verona, Italy.
Serena ZanzoniCentro Piattaforme Tecnologiche, University of Verona, Verona, Italy.
Domenico GirelliDepartment of Medicine, Internal Medicine Section D, University of Verona, Verona, Italy.
Ernesto CrisafulliDepartment of Medicine, Internal Medicine Section D, University of Verona, Verona, Italy.
Sergio FerrariDepartment of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Verona, Italy.
Stefano TamburinDepartment of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Verona, Italy. stefano.tamburin@univr.it.ORCID 0000-0002-1561-2187
University of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 survivors may report persistent symptoms that resemble myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). We explored (a) ME/CFS-like symptom prevalence and (b) whether axonal, inflammatory, and/or lung changes may contribute to ME/CFS-like symptoms in SARS-CoV-2 survivors through clinical, neuropsychiatric, neuropsychological, lung function assessment, and serum neurofilament light chain, an axonal damage biomarker. ME/CFS-like features were found in 27% of our sample. ME/CFS-like group showed worse sleep quality, fatigue, pain, depressive symptoms, subjective cognitive complaints, Borg baseline dyspnea of the 6-min walking test vs. those without ME/CFS-like symptoms. These preliminary findings raise concern on a possible future ME/CFS-like pandemic in SARS-CoV-2 survivors.

Indexed as

AdultAgedCOVID-19Fatigue Syndrome, ChronicFemaleHumansMaleMiddle AgedPrevalenceSARS-CoV-2CognitionCOVID-19FatigueFunctional neurological disordersMood alterationsViral infection

Identifiers

PMID34341960
PMCPMC8328351
OpenAlexW3187955946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.